Prevention of HIV and STDs in Drug Using Women

NACompletedINTERVENTIONAL
Enrollment

501

Participants

Timeline

Start Date

August 31, 2000

Primary Completion Date

November 30, 2004

Study Completion Date

November 30, 2004

Conditions
HIVSexually Transmitted DiseasesSubstance Abuse
Interventions
BEHAVIORAL

NIDA Cooperative Agreement Standard Intervention plus HIV/STD testing

At the end of Baseline Session I, HIV pre-test counseling, per the NIDA Cooperative Agreement, was delivered, along with education about STD prevention, and biological samples were collected to test for HIV, Hepatitis C, syphilis, chlamydia and gonorrhea. At Baseline Session II, HIV post-test counseling was conducted and women were given their random group assignment.

BEHAVIORAL

Standard Intervention plus Well-Woman Exam

At the end of Baseline Session I, HIV pre-test counseling, per the NIDA Cooperative Agreement, was delivered, along with education about STD prevention, and biological samples were collected to test for HIV, Hepatitis C, syphilis, chlamydia and gonorrhea. At Baseline Session II, HIV post-test counseling was conducted and women were given their random group assignment. This group was assigned to additionally receive a well-woman examination within seven days.

BEHAVIORAL

Standard Intervention plus Well-Woman Exam and Peer-Delivered Intervention

At the end of Baseline Session I, HIV pre-test counseling, per the NIDA Cooperative Agreement, was delivered, along with education about STD prevention, and biological samples were collected to test for HIV, Hepatitis C, syphilis, chlamydia and gonorrhea. At Baseline Session II, HIV post-test counseling was conducted and women were given their random group assignment. This group was assigned to receive a well-woman exam within seven days along with four two-hour peer-delivered educational sessions, covering health and nutrition, stress and coping, substance abuse, and HIV/AIDS.

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Washington University School of Medicine

OTHER

NCT01235091 - Prevention of HIV and STDs in Drug Using Women | Biotech Hunter | Biotech Hunter